See more : Maanshan Iron & Steel Company Limited (0323.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Intermedical Care and Lab Hospital Public Company Limited (IMH.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Intermedical Care and Lab Hospital Public Company Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Tae Kwang Corporation (023160.KQ) Income Statement Analysis – Financial Results
- EQT Holdings Limited (EQT.AX) Income Statement Analysis – Financial Results
- Kora Saúde Participações S.A. (KRSA3.SA) Income Statement Analysis – Financial Results
- Cannae Holdings, Inc. (CNNE) Income Statement Analysis – Financial Results
- Speqta AB (publ) (SPEQT.ST) Income Statement Analysis – Financial Results
Intermedical Care and Lab Hospital Public Company Limited (IMH.BK)
About Intermedical Care and Lab Hospital Public Company Limited
Intermedical Care and Lab Hospital Public Company Limited operates a network of private hospitals. The company offers occupational health services that include annual health checkups, health risk assessments, and pre-occupational checkups, as well as health checkup services for foreign workers, outpatient department services, vaccination, and first aid and cardiopulmonary resuscitation training services. It also provides environment monitoring services, such as occupational health and safety monitoring, vent air quality monitoring, general atmospheric monitoring, and water quality monitoring services, as well as monitoring, sample collection, and analysis services according to the environmental impact assessment protocol. The company was founded in 1996 and is headquartered in Bangkok, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 669.61M | 639.83M | 942.64M | 238.21M | 333.93M | 320.25M | 273.59M | 285.51M | 212.27M |
| Cost of Revenue | 426.93M | 304.85M | 315.55M | 180.22M | 234.75M | 216.30M | 169.46M | 166.05M | 84.65M |
| Gross Profit | 242.68M | 334.99M | 627.09M | 57.98M | 99.18M | 103.95M | 104.13M | 119.46M | 127.63M |
| Gross Profit Ratio | 36.24% | 52.36% | 66.53% | 24.34% | 29.70% | 32.46% | 38.06% | 41.84% | 60.12% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 161.65M | 103.98M | 84.17M | 63.12M | 67.53M | 67.67M | 67.42M | 64.03M | 66.98M |
| Selling & Marketing | 17.10M | 20.33M | 19.78M | 15.26M | 19.66M | 17.11M | 17.71M | 18.05M | 5.38M |
| SG&A | 178.75M | 124.31M | 103.96M | 78.38M | 87.18M | 84.78M | 85.12M | 76.94M | 72.37M |
| Other Expenses | -7.04M | -11.37M | -10.25M | -4.34M | -2.19M | 2.22M | 1.73M | 0.00 | 0.00 |
| Operating Expenses | 178.75M | 112.94M | 93.71M | 74.04M | 85.00M | 82.56M | 83.39M | 76.94M | 72.37M |
| Cost & Expenses | 598.64M | 417.78M | 409.26M | 254.26M | 319.75M | 298.87M | 252.85M | 242.99M | 157.01M |
| Interest Income | 0.00 | 10.82M | 8.75M | 1.54M | 3.82M | 0.00 | 0.00 | 349.93K | 79.59K |
| Interest Expense | 36.49M | 10.82M | 8.75M | 1.54M | 3.82M | 3.55M | 3.95M | 0.00 | 0.00 |
| Depreciation & Amortization | 42.34M | 35.77M | 36.52M | 25.60M | 18.31M | 18.16M | 20.07M | 19.59M | 19.22M |
| EBITDA | 113.31M | 257.82M | 568.07M | 9.74M | 32.80M | 39.99M | 43.30M | 66.77M | 76.57M |
| EBITDA Ratio | 16.92% | 40.29% | 60.46% | 4.01% | 9.82% | 12.35% | 14.91% | 21.75% | 35.08% |
| Operating Income | 70.97M | 222.05M | 531.56M | -16.06M | 14.18M | 21.39M | 20.74M | 42.52M | 55.26M |
| Operating Income Ratio | 10.60% | 34.70% | 56.39% | -6.74% | 4.25% | 6.68% | 7.58% | 14.89% | 26.03% |
| Total Other Income/Expenses | -36.49M | -10.82M | -8.75M | -1.54M | -3.32M | -3.11M | -1.45M | 4.32M | 2.02M |
| Income Before Tax | 34.48M | 211.23M | 522.80M | -17.39M | 10.86M | 18.28M | 19.28M | 46.84M | 57.28M |
| Income Before Tax Ratio | 5.15% | 33.01% | 55.46% | -7.30% | 3.25% | 5.71% | 7.05% | 16.40% | 26.98% |
| Income Tax Expense | 12.73M | 38.12M | 100.10M | -786.80K | 358.19K | 4.21M | 4.43M | 9.25M | 11.33M |
| Net Income | 21.48M | 173.11M | 422.70M | -16.61M | 10.50M | 14.07M | 14.85M | 37.58M | 45.94M |
| Net Income Ratio | 3.21% | 27.06% | 44.84% | -6.97% | 3.14% | 4.39% | 5.43% | 13.16% | 21.64% |
| EPS | 0.10 | 0.81 | 1.97 | -0.08 | 0.05 | 0.07 | 0.07 | 0.17 | 0.21 |
| EPS Diluted | 0.10 | 0.81 | 1.97 | -0.08 | 0.05 | 0.07 | 0.07 | 0.17 | 0.21 |
| Weighted Avg Shares Out | 214.00M | 214.00M | 214.74M | 215.00M | 215.00M | 215.00M | 215.00M | 215.00M | 215.00M |
| Weighted Avg Shares Out (Dil) | 214.00M | 214.00M | 214.74M | 215.00M | 215.00M | 215.00M | 215.00M | 215.00M | 215.00M |
Source: https://incomestatements.info
Category: Stock Reports